Accéder au contenu
Merck

Study on the bioavailability of baicalin-phospholipid complex by using HPLC.

Biomedical chromatography : BMC (1999-10-27)
J Wu, D Chen, R Zhang
RÉSUMÉ

A complex of baicalin with soy phospholipid was prepared to improve the bioabsorption of baicalin. A simple and sensitive HPLC method was developed for baicalin determination in rat plasma. It was shown that its plasma concentration reached a peak of 0.42 microgram/mL 5.3 h after oral administration, 600 mg/kg. However, after intake of its phospholipid complex, a peak of 0.90-microgram/mL occurred at a later time, 6.1 h. The elimination of the complex tended to be slower than that of the free drug. There was a significant difference in the mean area under the concentration-time curves (AUC) between the free drug and the complex (p < 0.01).

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
3,5-Dinitrobenzoic acid, 99%